Effectiveness of Omega-3 Fatty Acids Versus Placebo in Subjects at Ultra-High Risk for Psychosis: The PURPOSE Randomized Clinical Trial
Inge Winter-van Rossum(University Medical Center Utrecht), Jordina Tor Fabra, Rune A. Kroken(Haukeland University Hospital), Federica Piras(Fondazione Santa Lucia), Gregor Berger(University Hospital of Zurich), Fabian Probst, Susanne Walitza(University of Würzburg), Paolo Fiori Nastro(Sapienza University of Rome), Inmaculada Baeza(Centro de Investigación Biomédica en Red de Salud Mental), Adriana Fortea, Joaquín Galvañ, Gisela Sugranyes, Margot I. E. Slot(University Medical Center Utrecht), Montserrat Dolz(Hospital Sant Joan de Déu Barcelona), Covadonga M. Díaz‐Caneja(Hospital General Universitario Gregorio Marañón), Mauro Ferrara(Sapienza University of Rome), Elena de la Serna, Matthijs G. Bossong(Utrecht University), Miriam Ayora, Hendrika H. van Hell(University Medical Center Utrecht), Daniela Vecchio(Fondazione Santa Lucia), Manuel Durán-Cutilla, Dorieke Brink- Kwakkel(University Medical Center Utrecht), Orly Lavan(Schneider Children's Medical Center), Elena Monducci(Sapienza University of Rome), Soraya Otero(Marqués de Valdecilla University Hospital), Stephen M. Lawrie(University of Edinburgh), Maria Schipper(University Medical Center Utrecht), Valeria Mammarella, Liem Baldinger, Alan Apter(Schneider Children's Medical Center), Monika Schlögelhofer, Gottfried Maria Barth, Jill Bjarke, H.N. Aschauer(Bioinstitut), Nerisa Banaj(Fondazione Santa Lucia), Christian Scharinger(Medical University of Vienna), Valentina Ciullo(Fondazione Santa Lucia), Gianfranco Spalletta(Fondazione Santa Lucia), Tobias Renner(University of Würzburg), Elena Müller, A. Ter Maat(Amsterdam UMC Location University of Amsterdam), A. Maffucci, Margarita Miguel Corredera, Linn Marie Elise Aaberg, Annette Conzelmann(PFH Private University of Applied Sciences)
Cited by 4
Related Papers
New insights into the genetic etiology of Alzheimer’s disease and related dementias
|Nature Genetics|2022|2.5k
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
|American Journal of Psychiatry|2016|1.1k
Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis
|The Lancet Psychiatry|2017|884
Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group
|Molecular Psychiatry|2017|733
ENIGMA and global neuroscience: A decade of large-scale studies of the brain in health and disease across more than 40 countries
|Translational Psychiatry|2020|702